2021British Journal of DermatologyOpen access

Most rare subtypes of cutaneous lymphoma display variable CD30 expression: analysis of the German Cutaneous Lymphoma Network

Ulrike Wehkamp, Christina Mitteldorf, Sarja Stendel, René Stranzenbach, Jan Peter Nicolay, Marion Wobser, Michael Weichenthal, Roland Schneiderbauer, C.‐D. Klemke, Uwe Hillen, Werner Kempf, Chalid Assaf

Open full text 9 citations

Abstract

coding for the IFN-induced Mx protein in skin biopsies from patients with chilblains. 4 The Mx protein sequesters viral factors required for viral replication.6 Furthermore, an IFN-induced transmembrane protein may inhibit coronavirus replication.This could explain why PCR tests are mostly negative in patients with suspected COVID-19 chilblains. 4 Battesti and Descamps reported that patients with moderately severe COVID-19 had high circulating levels of IFN-1. 4 We hypothesize that in young adults with efficient innate immune responses, the IFN-1 pathway inhibits the replication of SARS-CoV-2 and dampens the symptoms of COVID-19.In parallel, activation of the IFN-1 pathway might lead to manifestations that have been already described in interferonopathies like lupus (i.e.chilblains).The inhibition of viral replication might explain the negative RT-PCR and serological test results in the present case.To conclude, we report on a case of recurrent chilblains, the appearances of which coincided with the epidemic peaks in France and contact with a SARS-CoV-2-positive close relative.Our observation reinforces the hypothesis of a causal relationship between SARS-CoV-2 infection and chilblains.It also raises the question of whether this manifestation is likely to occur or recur during contact with SARS-CoV-2 components (e.g. during a mass vaccination campaign).

Open-access reader

About this research paper

What this paper is about

coding for the IFN-induced Mx protein in skin biopsies from patients with chilblains. 4 The Mx protein sequesters viral factors required for viral replication.6 Furthermore, an IFN-induced transmembrane protein may inhibit coronavirus replication.This could explain why PCR tests are mostly negative in patients with suspected COVID-19 chilblains. 4 Battesti and Descamps reported that patients with moderately severe COVID-19 had high circulating levels of IFN-1. 4 We hypothesize that in young adults with efficient innate immune responses, the IFN-1 pathway inhibits the replication of SARS-CoV-2 and dampens the symptoms of COVID-19.In parallel, activation of the IFN-1 pathway might lead to manifestations that have been already described in interferonopathies like lupus (i.e.chilblains).The inhibition of viral replication might explain the negative RT-PCR and serological test results in the present case.To conclude, we report on a case of recurrent chilblains, the appearances of which coincided with the epidemic peaks in France and contact with a SARS-CoV-2-positive close relative.Our observation reinforces the hypothesis of a causal relationship between SARS-CoV-2 infection and chilblains.It also raises the question of whether this manifestation is likely to occur or recur during contact with SARS-CoV-2 components (e.g. during a mass vaccination campaign).

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

coding for the IFN-induced Mx protein in skin biopsies from patients with chilblains. 4 The Mx protein sequesters viral factors required for viral replication.6 Furthermore, an IFN-induced transmembrane protein may inhibit coronavirus replication.This could explain why PCR tests are mostly negative in patients with suspected COVID-19 chilblains. 4 Battesti and Descamps reported that patients with moderately severe COVID-19 had high circulating levels of IFN-1. 4 We hypothesize that in young adults with efficient innate immune responses, the IFN-1 pathway inhibits the replication of SARS-CoV-2 and dampens the symptoms of COVID-19.In parallel, activation of the IFN-1 pathway might lead to manifestations that have been already described in interferonopathies like lupus (i.e.chilblains).The inhibition of viral replication might explain the negative RT-PCR and serological test results in the present case.To conclude, we report on a case of recurrent chilblains, the appearances of which coincided with the epidemic peaks in France and contact with a SARS-CoV-2-positive close relative.Our observation reinforces the hypothesis of a causal relationship between SARS-CoV-2 infection and chilblains.It also raises the question of whether this manifestation is likely to occur or recur during contact with SARS-CoV-2 components (e.g. during a mass vaccination campaign).

Key concepts: CD30, Brentuximab vedotin, Mycosis fungoides, Medicine, Cutaneous lymphoma, Lymphoma, Anaplastic large-cell lymphoma, Cutaneous T-cell lymphoma

Related papers

Back to paper searchBrowse research topicsOriginal source
Most rare subtypes of cutaneous lymphoma display variable CD30 expression: analysis of the German Cutaneous Lymphoma Network — Research Paper | ScholarLens